Heron Therapeuti Stock Today
| HRTX Stock | USD 2.77 0.16 5.46% |
Performance8 of 100
| Odds Of DistressOver 74
|
Heron Therapeuti is trading at 2.77 as of the 18th of April 2024; that is -5.46 percent decrease since the beginning of the trading day. The stock's open price was 2.93. Heron Therapeuti has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Heron Therapeuti are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of March 2024 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 26th of August 1987 | Category Healthcare | Classification Health Care |
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California. Heron Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 150.33 M outstanding shares of which 25.55 M shares are currently shorted by private and institutional investors with about 9.17 trading days to cover. More on Heron Therapeuti
Moving against Heron Stock
| 0.49 | LPTX | Leap Therapeutics Financial Report 20th of May 2024 | PairCorr |
| 0.46 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 9th of May 2024
Heron Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Heron Therapeuti's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Heron Therapeuti or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, Director | Barry Quart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Cancer Fighters (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Cancer Fighters, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Heron Therapeuti report their recommendations after researching Heron Therapeuti's financial statements, talking to executives and customers, or listening in on Heron Therapeuti's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Heron Therapeuti. The Heron consensus assessment is calculated by taking the average forecast from all of the analysts covering Heron Therapeuti. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators obtained from Heron Therapeuti's historical financial statements, Heron Therapeuti may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. Financial strength of Heron Therapeuti is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Heron Therapeuti's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Heron Therapeuti's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Heron Therapeuti's financial leverage. It provides some insight into what part of Heron Therapeuti's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Heron Therapeuti (HRTX) is traded on NASDAQ Exchange in USA. It is located in 4242 Campus Point Court, San Diego, CA, United States, 92121 and employs 126 people. Heron Therapeuti is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 440.46 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Heron Therapeuti's market, we take the total number of its shares issued and multiply it by Heron Therapeuti's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Heron Therapeuti conducts business under Biotechnology sector and is part of Health Care industry. The entity has 150.33 M outstanding shares of which 25.55 M shares are currently shorted by private and institutional investors with about 9.17 trading days to cover.
Heron Therapeuti currently holds about 83.54 M in cash with (58.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.81.
Check Heron Therapeuti Probability Of Bankruptcy
Ownership AllocationHeron Therapeuti has a total of 150.33 Million outstanding shares. The majority of Heron Therapeuti outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Heron Therapeuti to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Heron Therapeuti. Please pay attention to any change in the institutional holdings of Heron Therapeuti as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Heron Ownership Details
Heron Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Heron Therapeuti jumping above the current price in 90 days from now is about 29.51%. The Heron Therapeuti probability density function shows the probability of Heron Therapeuti stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.7096. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Heron Therapeuti will likely underperform. Additionally, heron Therapeuti has an alpha of 0.4453, implying that it can generate a 0.45 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Heron Therapeuti to move above the current price in 90 days from now is about 29.51 (This Heron Therapeuti probability density function shows the probability of Heron Stock to fall within a particular range of prices over 90 days) .
Heron Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Heron Therapeuti that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Heron Therapeuti's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Heron Therapeuti's value.| Instituion | Recorded On | Shares | |
| State Street Corporation | 2023-12-31 | 2.5 M | |
| Jw Asset Management, Llc | 2023-12-31 | 2.3 M | |
| Orchard Capital Management, Llc | 2023-12-31 | 2.2 M | |
| Monaco Asset Management | 2023-12-31 | 2.2 M | |
| Goldman Sachs Group Inc | 2023-12-31 | 2 M | |
| Renaissance Technologies Corp | 2023-12-31 | 1.9 M | |
| Tang Capital Management Llc | 2023-09-30 | 1.9 M | |
| Congress Park Capital Llc | 2023-12-31 | 1.8 M | |
| Millennium Management Llc | 2023-12-31 | 1.2 M | |
| Rubric Capital Management Lp | 2023-12-31 | 26.7 M | |
| Vanguard Group Inc | 2023-12-31 | 8.3 M |
Heron Therapeuti Historical Income Statement
Heron Therapeuti Income Statement is one of the three primary financial statements used for reporting Heron's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Heron Therapeuti revenue and expense. Heron Therapeuti Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Heron Therapeuti's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 4.1 M in 2024, despite the fact that Operating Income is likely to grow to (105.1 M). View More FundamentalsHeron Stock Against Markets
Picking the right benchmark for Heron Therapeuti stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Heron Therapeuti stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Heron Therapeuti is critical whether you are bullish or bearish towards Heron Therapeuti at a given time. Please also check how Heron Therapeuti's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Heron Therapeuti without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Heron Therapeuti Corporate Directors
Heron Therapeuti corporate directors refer to members of a Heron Therapeuti board of directors. The board of directors generally takes responsibility for the Heron Therapeuti's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Heron Therapeuti's board members must vote for the resolution. The Heron Therapeuti board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Stephen Davis | Director | Profile | |
| John Poyhonen | Independent Director | Profile | |
| Kimberly Manhard | Independent Director | Profile | |
| Christian Waage | Director | Profile |
How to buy Heron Stock?
Before investing in Heron Therapeuti, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Heron Therapeuti. To buy Heron Therapeuti stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Heron Therapeuti. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Heron Therapeuti stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Heron Therapeuti stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Heron Therapeuti stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Heron Therapeuti, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.
Already Invested in Heron Therapeuti?
The danger of trading Heron Therapeuti is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Heron Therapeuti is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Heron Therapeuti. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Heron Therapeuti is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Heron Therapeuti offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Heron Therapeuti's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Heron Therapeuti Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Heron Therapeuti Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heron Therapeuti. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Heron Stock analysis
When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Heron Therapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heron Therapeuti. If investors know Heron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heron Therapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Revenue Per Share 0.92 | Quarterly Revenue Growth 0.14 | Return On Assets (0.25) | Return On Equity (24.09) |
The market value of Heron Therapeuti is measured differently than its book value, which is the value of Heron that is recorded on the company's balance sheet. Investors also form their own opinion of Heron Therapeuti's value that differs from its market value or its book value, called intrinsic value, which is Heron Therapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heron Therapeuti's market value can be influenced by many factors that don't directly affect Heron Therapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heron Therapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heron Therapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heron Therapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.